Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Stem Cells. 2013 Jan;31(1):104–116. doi: 10.1002/stem.1215

Figure 2. tEGF protects differentiating osteogenic cells from death signals.

Figure 2

Fluorochrome inhibitor of caspase assay (FLICA) stained imhMSC (Magnification 10×, Scale bar 50μm) grown on mock/tEGF surfaces under osteogenic conditions, after 8 hours of treatment with cytokines on Day 0/ Day 15/ Day 30 (A). Quantification of FLICA intensity normalized to cell numbers and optical background (B). Shown are representative photomicrographs of cells and graphs of mean ± s.e.m of two independent experiments.